AzTrials
AzTrials

Post-operation DeliriumNCT02550626

Exploring the Relationship Between Alpha-synucleinopathy Related Non-motor Symptom and Post-op. Delirium in Elderly Patients With Spine Surgery

An observational study of Post-operation Delirium and Alpha-synucleinopathy Related Non-motor Symptom, run by Yonsei University at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Hypothesis is that the presence of a-synucleinopathy related non motor symptoms could be predictive factor for post-operative delirium. During 72hrs after spine surgery, investigator will observe occurrence of post-operative delirium, and analysis difference of a-synucleinopathy related non motor symptoms between 2… Read more about this study

Who is it for?
Ages 65 years and olderHealthy volunteers can take part
How many people
106 participants
Where
1 siteSouth Korea
Study dates
Oct 2015to Aug 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Study population: spine surgery

Who may be able to join

  • Age 65 and older patients
  • Scheduled to perform spine surgery in severance hospital

Who cannot join

  • Previous delirium history
  • Previous chemotherapy or radiotherapy within 1yr due to underlying cancer.
  • Severe hepatic/renal dysfunction

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Department of Neurology, Yonsei University College of Medicine

    Seoul, Seou, 120-752

Other trials in South Korea

About this study

Hypothesis is that the presence of a-synucleinopathy related non motor symptoms could be predictive factor for post-operative delirium. During 72hrs after spine surgery, investigator will observe occurrence of post-operative delirium, and analysis difference of a-synucleinopathy related non motor symptoms between 2 groups.

Read the detailed description

Postoperative delirium appear approximately 10-70% of patients older than 65 yrs undergoing surgery and it is strongly associated with poor surgical outcome. The clinical characteristics of postoperative delirium are fluctuating attention, visual hallucination, disorganized thought and alter sleep-wake cycles. This is quite similar to core features of α-synuclein-related cognitive disorders such as parkinson's disease dementia and dementia with lewy body. At that point, investigator thought that postoperative delirium is preclinical stage of a-synucleinopathy. In other words, a-synuclein related disorders and postoperative delirium may share an underlying neurochemical change in their pathogenesis.

investigator will recruit age 65 and older patients scheduled to perform spine surgery. The pre-operative evaluation include neurologic exam, baseline cognitive function and a-synucleinopathy related non motor symptoms through Questionnaires.

Keywords
delirium, alpha synucleinopathy, spine surgery
Medical subject headings
Delirium, Synucleinopathies

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT02550626
Study groupRoleWhat they receive
Deliriumoccurrence of post-operative delirium
No deliriumno presence of post-operative delirium

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. existence of anosomia

    During 72hrs after spine surgery, investigator will observe occurrence of post-operative delirium, and analysis difference of anosmia symptoms before operation between 2 groups. The cross-cultural smell identification test will be used for measure of anosmia. investigator define anosmia as less than 4 score on the cross-cultural smell identification test. This study is not interventional study, because measure of anosmia by smell kit will not develop post-operation delirium more. (investigator will classify our patients into normosmia if the CCSIT score is 9 or higher, and hyposmia if the CCSIT score is 6 or less. Patients whose CCSIT scores are 7 or 8 will be regarded as borderline.).

    Measured: A day before operation

Secondary outcomes (6)
  1. existence of constipation

    Questionnaire (Constipation scoring system (Agachanet al., 1996) \& Rome III Questionnaire (Constipation : Yes/No)

    Measured: A day before operation

  2. existence of orthostatic hypotension

    Check 3 position BP (define orthostatic hypotension - sustained reduction of systolic blood pressure of at least 20 mmHg or diastolic blood pressure of 10 mmHg within 3 min of standing, / Questionnaire (orthostatic hypotension symptom assessment \& Orthostatic hypotension daily activities scale) (orthostatic hypotension: Yes/No)

    Measured: A day before operation

  3. existence of insomnia

    Questionnaire (Epworth Sleepiness Scale (ESS) : total score 0-24)

    Measured: A day before operation

  4. existence of depression

    Questionnaire (Beck depression inventory, total score 0-63)

    Measured: A day before operation

  5. existence of anxiety

    Questionnaire (The Parkinson Anxiety Scale, total score 0-48)

    Measured: A day before operation

  6. existence of REM sleep behavior disorder

    Questionnaire (RBD screening questionnaire, total score 0-13) :These questionnaires \& checking 3-position BP will not effect the occurence of post-operation delirium

    Measured: A day before operation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Sep 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionAug 2016
  4. Study completionAug 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
106 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02550626
Sponsor's protocol ID
4-2015-0365
Status last verified
Feb 2019
First submitted
16 Jul 2015
Last updated
15 Feb 2019
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Post-operation Delirium and Alpha-synucleinopathy Related Non-motor Symptom, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

existence of anosomia (time frame: A day before operation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Feb 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in